| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 2 |
| 1 | METHOTREXATE | 2 |
| 2 | METHOTREXATE SODIUM | 2 |
| 3 | ACETAMINOPHEN | 1 |
| 4 | ACETAMINOPHEN 500MG | 1 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 6 | ASPIRIN | 1 |
| 7 | ASPIRIN 325 MG | 1 |
| 8 | ASPIRIN 81 MG | 1 |
| 9 | CISPLATIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRANEXAMIC ACID | 1 | 0.0001 |
| 1 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| 2 | NEBIVOLOL HYDROCHLORIDE | 1 | 0.0000 |
| 3 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 4 | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0.0000 |
| 5 | CISPLATIN | 1 | 0.0000 |
| 6 | INFLIXIMAB | 2 | 0.0000 |
| 7 | DENOSUMAB | 1 | 0.0000 |
| 8 | RITUXIMAB | 1 | 0.0000 |
| 9 | METHOTREXATE SODIUM | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 2 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |